pub 30day FRN

48746

Federal Register / Vol. 86, No. 166 / Tuesday, August 31, 2021 / Notices

Director who reports to the Assistant
Secretary for Health.
2. OCCHE shall work with the
Immediate Office of the Secretary, Staff
Divisions, and Operating Divisions to
focus on:
—Identifying communities with
disproportionate exposures to climate
hazards and vulnerable populations.
—Addressing health disparities
exacerbated by climate impacts to
enhance community health resilience.
—Promoting and translating research on
public health benefits of multisectoral climate actions.
—Supporting regulatory efforts to
reduce greenhouse gas emissions and
criteria air pollution throughout the
health care sector, including
participating suppliers and providers.
—Fostering innovation in climate
adaptation and resilience for people
and communities experiencing a
disproportionate share of climate
impacts and health inequities.
—Providing expertise and coordination
to the White House and other Federal
agencies related to climate change and
health equity deliverables and
activities, including executive order
implementation, and reporting on
health adaptation actions under the
United Nations Framework
Convention on Climate Change.
—Promoting training opportunities to
build the climate and health
workforce and empower
communities.
—Exploring opportunities to partner
with the philanthropic and private
sectors to support innovative
programming to address disparities
and health sector transformation.
Delegations of Authority

khammond on DSKJM1Z7X2PROD with NOTICES

Directives or orders made by the
Secretary or the Assistant Secretary for
Health, including all delegations and redelegations of authority made to
officials and employees of affected
organizational components will
continue in force pending further
delegation, if allowed, provided they are
consistent with this realignment.
Andrea Palm,
Deputy Secretary.
[FR Doc. 2021–18794 Filed 8–30–21; 8:45 am]
BILLING CODE 4150–03–P

VerDate Sep<11>2014

20:08 Aug 30, 2021

Jkt 253001

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Center for Advancing
Translational Sciences; Notice of
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Center for
Advancing Translational Sciences
Advisory Council.
The meeting will be open to the
public as indicated below. The open
session will be videocast and can be
accessed from the NIH Videocasting and
Podcasting website (http://
videocast.nih.gov). Individuals who
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Center for
Advancing Translational Sciences Advisory
Council.
Date: September 23–24, 2021.
Closed: September 23, 2021, 10:30 a.m. to
12:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Center for Advancing
Translational Sciences, National Institutes of
Health, One Democracy Plaza, 6701
Democracy Boulevard, Room 987/989,
Bethesda, MD 20892 (Virtual Meeting).
Open: September 23, 2021, 1:00 p.m. to
5:00 p.m.
Agenda: Report from the Institute Director
and other staff.
Place: National Center for Advancing
Translational Sciences, National Institutes of
Health, One Democracy Plaza, 6701
Democracy Boulevard, Room 987/989,
Bethesda, MD 20892 (Virtual Meeting).
Open: September 24, 2021, 1:00 p.m. to
5:00 p.m.
Agenda: To view and discuss Clearance of
Concepts.
Place: National Center for Advancing
Translational Sciences, National Institutes of
Health, One Democracy Plaza, 6701
Democracy Boulevard, Room 987/989,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Anna L. Ramsey-Ewing,
Ph.D., Executive Secretary, National Center

PO 00000

Frm 00088

Fmt 4703

Sfmt 4703

for Advancing Translational Sciences, One
Democracy Plaza, Room 1072, Bethesda, MD
20892, 301–435–0809, anna.ramseyewing@
nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice no later than 15 days after the
meeting at NCATSCouncilInput@
mail.nih.gov. The statement should include
the name, address, telephone number and
when applicable, the business or professional
affiliation of the interested person.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.859, Pharmacology,
Physiology, and Biological Chemistry
Research; 93.350, B—Cooperative
Agreements; 93.859, Biomedical Research
and Research Training, National Institutes of
Health, HHS)
Dated: August 25, 2021.
David W. Freeman,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–18727 Filed 8–30–21; 8:45 am]
BILLING CODE 4140–01–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Submission for OMB Review; 30-Day
Comment Request; Evaluation of
Office of Acquisitions System (OASYS)
and FFRDC Contract Administration
System (FCAS) Vendor Portals
National Cancer Institute (NCI)
AGENCY:

National Institutes of Health,

HHS.
ACTION:

Notice.

In compliance with the
Paperwork Reduction Act of 1995, the
National Institutes of Health (NIH) has
submitted to the Office of Management
and Budget (OMB) a request for review
and approval of the information
collection listed below.
DATES: Comments regarding this
information collection are best assured
of having their full effect if received
within 30-days of the date of this
publication.
ADDRESSES: Written comments and
recommendations for the proposed
information collection should be sent
within 30 days of publication of this
notice to www.reginfo.gov/public/do/
PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function.
FOR FURTHER INFORMATION CONTACT:
Marla Jacobson, 9609 Medical Center
Drive, MSC 9742, Rockville, MD 20850
or call non-toll-free number 240–276–
SUMMARY:

E:\FR\FM\31AUN1.SGM

31AUN1

48747

Federal Register / Vol. 86, No. 166 / Tuesday, August 31, 2021 / Notices
5267 or Email your request, including
your address to: marla.jacobson@
nih.gov. Formal requests for additional
plans and instruments must be
requested in writing.
SUPPLEMENTARY INFORMATION: This
proposed information collection was
previously published in the Federal
Register on May 19, 2021, page 27093
(Vol. 86 FR 27093) and allowed 60 days
for public comment. No public
comments were received. The National
Cancer Institute (NCI), National
Institutes of Health, may not conduct or
sponsor, and the respondent is not
required to respond to, an information
collection that has been extended,
revised, or implemented on or after
October 1, 1995, unless it displays a
currently valid OMB control number.
In compliance with Section
3507(a)(1)(D) of the Paperwork
Reduction Act of 1995, the National
Institutes of Health (NIH) has submitted
to the Office of Management and Budget
(OMB) a request for review and
approval of the information collection
listed below.
Proposed Collection: Evaluation of
Office of Acquisitions System (OASYS)

email (future OASYS Vendor Portal
Users) and were (current FCAS Vendor
Portal Users) to individual OA
recipients. The FCAS Vendor Portal and
in the future, the OASYS Vendor Portal
will serve as a one-stop shop for
transmission of requests, reports,
deliverables and other correspondence
due on numerous research and
development, in support of R&D
contracts as well as those contract
vehicles awarded using various Federal
Acquisition Procedures including but
not limited to FAR Part 8, Required
Sources of Supplies and Services, FAR
Part 13, Simplified Acquisition
Procedures, and FAR Part 12,
Acquisition of Commercial Items. These
reports and deliverables cover a wide
variety of topics in the areas of cancer
research including prevention,
detection, diagnosis, and control.
OMB approval is requested for 3
years. There are no costs to respondents
other than their time. The total
estimated annualized burden hours are
232.

and FFRDC Contract Administration
System (FCAS) Vendor Portals National
Cancer Institute (NCI), 0925–NEW,
Expiration Date XX/XX/XXXX, NEW,
National Cancer Institute (NCI),
National Institutes of Health (NIH).
Need and Use of Information
Collection: The National Cancer
Institute (NCI) Office of Acquisitions
(OA), located within the Office of the
Director (OD) in the Office of
Management (OM) at the National
Cancer Institute (NCI), awards and
administers contracts and simplified
acquisitions in support of the Institute’s
mission to prevent, diagnose and treat
cancer. During the acquisition process,
the OA ensures that customer service is
paramount, and communications are
open and continuous. Currently
requests and correspondence are sent to
and received from vendors through
email with the exception of the FFRDC
Contractor who submits through the
FCAS Vendor Portal which is in
production. To streamline processes,
increase transparency and gain
efficiencies, the OA developed OASYS
and FCAS vendor portals to replace
processes that are handled through

ESTIMATED ANNUALIZED BURDEN HOURS
Number of
responses per
respondent

Average time
per response
(in hours)

Total annual
burden hours

Type of respondent

Survey—OASYS ...............................
Survey—FCAS ..................................
Registration—OASYS .......................
Registration—FCAS ..........................
Data Field Information—OASYS ......
Data Field Information—FCAS .........
Add/Edit new Vendor User—OASYS
Add/Edit new Vendor User—FCAS ..

Individuals ........................................
Individuals ........................................
Corporations .....................................
Corporations .....................................
Individuals ........................................
Individuals ........................................
Corporations .....................................
Corporations .....................................

10
1
400
1
400
61
40
6

1
1
1
1
18
63
1
1

6/60
6/60
6/60
6/60
1/60
1/60
6/60
6/60

1
1
40
1
120
64
4
1

Totals .........................................

...........................................................

919

11,501

........................

232

Dated: August 26, 2021.
Vivian Horovitch-Kelley,
Project Clearance Liaison, National Cancer
Institute, National Institutes of Health.

Maryland, 20892, which was published
in the Federal Register on August 4,
2021, FR Doc 2021–16549, 86 FR 41983.
This notice is being amended to
change the start time for the second
Open session on September 1, 2021,
which will now be 12:30 p.m. and will
still end at 2:30 p.m. as listed. The
meeting is closed to the public.

[FR Doc. 2021–18767 Filed 8–30–21; 8:45 am]
BILLING CODE 4140–01–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES

Dated: August 25, 2021.
David W. Freeman,
Program Analyst, Office of Federal Advisory
Committee Policy.

National Institutes of Health
khammond on DSKJM1Z7X2PROD with NOTICES

Number of
respondents

Form name

National Institute of Environmental
Health Sciences; Amended Notice of
Meeting

[FR Doc. 2021–18725 Filed 8–30–21; 8:45 am]

Notice is hereby given of a change in
the meeting of the National Heart, Lung,
and Blood Advisory Council, August 31,
2021–September 1, 2021, National
Institutes of Health, Bethesda,

VerDate Sep<11>2014

20:08 Aug 30, 2021

Jkt 253001

BILLING CODE 4140–01–P

PO 00000

Frm 00089

Fmt 4703

Sfmt 4703

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Human Genome Research
Institute; Notice of Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Advisory
Council for Human Genome Research.
The meeting will be open to the
public as indicated below, the 94th
meeting of the National Advisory
Council for Human Genome Research
open session will be livestreamed and
available for viewing to the public from
https://www.genome.gov/eventcalendar/94th-Meeting-of-NationalAdvisory-Council-for-Human-Genome-

E:\FR\FM\31AUN1.SGM

31AUN1